These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11965083)

  • 1. Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts.
    Tellier P
    Ann Med Interne (Paris); 2001 Nov; 152(7):429-36. PubMed ID: 11965083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-clinics. The hue and cry over central appetite suppressants!].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
    [No Abstract]   [Full Text] [Related]  

  • 6. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
    Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary pulmonary hypertension and long-term use of appetite suppressants.
    Sztuke-Fournier A
    CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
    McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
    JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The French are wary of their drugs].
    Nau JY
    Rev Med Suisse; 2011 May; 7(296):1170-1. PubMed ID: 21728251
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitral valve disease associated with use of anorexigenic medications.
    Cheng TO
    Ann Thorac Surg; 1998 Jan; 65(1):298-9. PubMed ID: 9456151
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of obesity with drugs.
    Hirsch J
    Am J Clin Nutr; 1998 Jan; 67(1):2-4. PubMed ID: 9440366
    [No Abstract]   [Full Text] [Related]  

  • 12. Appetite suppressants and primary pulmonary hypertension in the United Kingdom.
    Thomas SH; Butt AY; Corris PA; Egan JJ; Higenbottam TW; Madden BP; Waller PC
    Br Heart J; 1995 Dec; 74(6):660-3. PubMed ID: 8541174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appetite-suppressant drugs and primary pulmonary hypertension.
    Fishman AP
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
    [No Abstract]   [Full Text] [Related]  

  • 14. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
    Rich S; Rubin L; Walker AM; Schneeweiss S; Abenhaim L
    Chest; 2000 Mar; 117(3):870-4. PubMed ID: 10713017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for obesity -- do the benefits outweigh the risks?
    Manson JE; Faich GA
    N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523
    [No Abstract]   [Full Text] [Related]  

  • 17. Obesity drugs and the heart.
    Connolly HM; McGoon MD
    Curr Probl Cardiol; 1999 Dec; 24(12):745-92. PubMed ID: 10609092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. After fen-phen.
    Cowley G; Springen K
    Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
    [No Abstract]   [Full Text] [Related]  

  • 19. Fen-phen's message to dentists.
    Hilsen K; Davis S; Iyer P
    J N J Dent Assoc; 1998; 69(1):37, 47. PubMed ID: 9584764
    [No Abstract]   [Full Text] [Related]  

  • 20. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?
    Voelkel NF; Clarke WR; Higenbottam T
    Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.